ERIN CADE: Open Payments
NPI 1578128575 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,814 in 100 payments from 16 companies in 2025. Trend: 2023 $831 · 2024 $1,918 · 2025 $1,814
Food & beverage: $1,763Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $412 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $378 |
| Janssen Biotech, Inc. | 12 | $241 |
| Regeneron Healthcare Solutions, Inc. | 4 | $110 |
| Pharmacosmos Therapeutics Inc. | 1 | $104 |
| QOL Medical, LLC | 6 | $99 |
| Janssen Scientific Affairs, LLC | 1 | $91 |
| Ardelyx, Inc. | 5 | $90 |
| Madrigal Pharmaceuticals | 3 | $79 |
| Lilly USA, LLC | 3 | $66 |
Products named: TREMFYA, ENTYVIO, RINVOQ, EOHILIA, LINZESS, DUPIXENT, MONOFERRIC, Sucraid.
Industry payments across IN — which companies pay providers there.
